Journal article
Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk
EA Tindall, G Severi, HN Hoang, CS Ma, P Fernandez, MC Southey, DR English, JL Hopper, CF Heyns, SG Tangye, GG Giles, VM Hayes
Carcinogenesis | OXFORD UNIV PRESS | Published : 2010
Abstract
Although inflammation is emerging as a candidate prostate cancer risk factor, the T-helper cytokine-rich [interleukins (IL)-5, 13 and 4] chromosomal region at 5q31.1 has been implicated in prostate cancer pathogenesis. In particular, IL-4 has been associated with prostate cancer progression, whereas the IL-4 -589C>T (rs2243250) promoter variant has been associated with differential gene expression. We genotyped rs2243250 and 11 tag single-nucleotide polymorphisms (SNPs) spanning 200 kb across the 5q31.1 region on 825 cases and 732 controls from the Risk Factors for Prostate Cancer Study. The minor alleles of rs2243250 and an IL-4 tagSNP rs2227284 were associated with a small increase in pros..
View full abstractRelated Projects (2)
Grants
Awarded by Cancer Council Victoria
Funding Acknowledgements
Cancer Institute of New South Wales Innovation Grant to V. M. H. (Fellow) and E.A.T. (PhD Scholar); National Health and Medical Research Council of Australia (NHMRC; #396407, #504700, #504702); Australian Rotary Health to E.A.T. (PhD Scholar). Infrastructure support was provided by the Children's Cancer Institute Australia and the Cancer Council Victoria. The Australian prostate cancer BioResource is supported by an Enabling Grant from the NHMRC (#290546).